MAIA Biotechnology, Inc. (MAIA)
1.15
+0.02
(+1.77%)
USD |
NYAM |
Oct 23, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Market Cap : 69.94M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 69.94M |
| October 22, 2026 | 68.72M |
| October 21, 2026 | 69.33M |
| October 20, 2026 | 68.12M |
| October 19, 2026 | 65.07M |
| October 16, 2026 | 66.90M |
| October 15, 2026 | 68.12M |
| October 14, 2026 | 68.12M |
| October 13, 2026 | 70.55M |
| October 12, 2026 | 71.76M |
| October 09, 2026 | 74.20M |
| October 08, 2026 | 69.94M |
| October 07, 2026 | 71.76M |
| October 06, 2026 | 72.37M |
| October 05, 2026 | 71.76M |
| October 02, 2026 | 72.37M |
| October 01, 2026 | 71.16M |
| September 30, 2026 | 71.76M |
| September 29, 2026 | 69.94M |
| September 28, 2026 | 71.76M |
| September 25, 2026 | 72.98M |
| September 24, 2026 | 76.02M |
| September 23, 2026 | 80.28M |
| September 22, 2026 | 83.32M |
| September 21, 2026 | 80.89M |
| Date | Value |
|---|---|
| September 18, 2026 | 79.67M |
| September 17, 2026 | 85.14M |
| September 16, 2026 | 85.14M |
| September 15, 2026 | 81.50M |
| September 14, 2026 | 84.54M |
| September 11, 2026 | 79.06M |
| September 10, 2026 | 79.67M |
| September 09, 2026 | 80.89M |
| September 08, 2026 | 79.67M |
| September 04, 2026 | 80.28M |
| September 03, 2026 | 80.89M |
| September 02, 2026 | 83.32M |
| September 01, 2026 | 79.06M |
| August 31, 2026 | 79.67M |
| August 28, 2026 | 80.89M |
| August 27, 2026 | 83.93M |
| August 26, 2026 | 84.54M |
| August 25, 2026 | 85.75M |
| August 24, 2026 | 82.10M |
| August 21, 2026 | 84.54M |
| August 20, 2026 | 83.93M |
| August 19, 2026 | 84.54M |
| August 18, 2026 | 83.32M |
| August 17, 2026 | 84.54M |
| August 14, 2026 | 85.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PEG Ratio | -0.2487 |
| Price to Book Value | 3.383 |
| Price | 1.15 |
| Earnings Yield | -55.11% |
| PEGY Ratio | -0.2487 |